Heart effects of antibodies in breast or colorectal cancer
Part of Cancer, Digestive system, Genetic & congenital, Heart & circulation clinical trials.
This study looks at whether certain antibodies that attack heart cells can affect heart function in people with breast or colorectal cancer. It may help doctors understand why some patients develop heart problems during cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have breast or colorectal cancer, whether it has spread or not
- You are currently receiving your first round of cancer treatment
- You do not have significant heart disease, autoimmune disease, or a weakened immune system
- You are not taking high-dose immunosuppressive drugs or other experimental treatments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how breast cancer medicines affect the heart. It may help doctors better prevent, spot early, and manage heart side effects from trastuzumab and/or anthracycline chemotherapy.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This study looks for early warning signs (biomarkers) of heart damage caused by cancer treatments. It is for people who have had cancer treatment, may have heart issues, or are about to start a treatment that could affect the heart.
This study looks at whether a simple blood test can spot early signs of heart damage from certain breast cancer treatments (anthracycline chemo or anti-HER2 drugs). The goal is to protect your heart while you get the cancer treatment you need.
This trial studies how a blood test marker (TRPC6) may help predict and prevent heart muscle damage and heart failure related to some breast cancer medicines. You may join if you’re starting or have received treatment that can stress the heart, or if you already have signs of treatment-related heart problems.
This study looks at how information about the heart may affect treatment decisions for people receiving radiation therapy for breast cancer. It aims to help reduce heart-related side effects from treatment.
Hear when a new Brugada Syndrome (BrS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.